Preclinical efficacy of targeting epigenetic mechanisms in AML with 3q26 lesions and EVI1 overexpression

Leukemia, Published online: 12 December 2023; doi:10.1038/s41375-023-02108-3Preclinical efficacy of targeting epigenetic mechanisms in AML with 3q26 lesions and EVI1 overexpression

Source: Leukemia - December 12, 2023 Category: Hematology Authors: Christine E. Birdwell Warren Fiskus Tapan M. Kadia Christopher P. Mill Koji Sasaki Naval Daver Courtney D. DiNardo Naveen Pemmaraju Gautam Borthakur John A. Davis Kaberi Das Sunil Sharma Stephen Horrigan Xinjia Ruan Xiaoping Su Joseph D. Khoury Hagop Kant Source Type: research